journal article·2026-02

α-Cyclodextrin mediated 3D printed ceramic/polymer composite scaffolds for immunomodulation and osteogenesis in bone defect repair

XiaoLong Chen, Lan Li, SiYi Huang, XiangLei Mo, TingTing Huang, YanJin Lu, JinXin Lin

Publisher page

Abstract

Bone tissue engineering scaffolds for bone defect treatment face numerous challenges, including mechanical mismatches and the lack of immune microenvironment modulation, often leading to implant failure. In this study, an innovative drug-loaded bioinspired ceramic/polymer composite scaffold was designed and fabricated using extrusion-based 3D printing technology, incorporating α-cyclodextrin (αCD) in a novel approach to improve interfacial compatibility and drug-loading efficiency. Hydroxyapatite (HA), the main component of natural bone, was employed as the inorganic phase to mimic the mineral structure of bone tissue. Sodium alginate (SA), a natural polymer, served as the organic phase, imparting mechanical strength and flexibility to the scaffold. To enhance phase compatibility, polyethylene glycol (PEG) was grafted onto the HA surface, and αCD was spontaneously threaded onto the PEG chains to form poly(pseudo)rotaxane structures. This approach further improved the mechanical performance of the scaffold. Additionally, melatonin (MT) was incorporated into the scaffold to enhance its osteogenic, anti-inflammatory, and antioxidant functions. To address MT's poor water solubility and bioavailability, αCD was utilized to encapsulate MT, enabling efficient and sustained release. The scaffold's physical and chemical properties, in vitro mineralization ability, biological functions, and in vivo performance in a rat calvarial defect model were systematically evaluated. Results demonstrated that the scaffold exhibited excellent biocompatibility, promoted osteogenesis, and provided antioxidant and anti-inflammatory effects, making it a promising and efficient solution for bone defect repair.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · 3D Printing in Biomedical Research · Advanced Drug Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (87)

Show source-provided references
1. Flavonoid-loaded biomaterials in bone defect repair10.3390/molecules28196888 ↗
2. Cellulose-based composite scaffolds for bone tissue engineering and localized drug delivery
3. Autograft, allograft, and bone graft substitutes: clinical evidence and indications for use in the setting of Orthopaedic trauma surgery10.1097/BOT.0000000000001420 ↗
4. The role of the immune microenvironment in bone regeneration10.7150/ijms.61080 ↗
5. A review of 3D polymeric scaffolds for bone tissue engineering: principles, fabrication techniques, immunomodulatory roles, and challenges10.3390/bioengineering10020204 ↗
6. 3D-printed zinc/magnesium-doped hydroxyapatite-polycaprolactone composite scaffolds for angiogenesis and osteogenesis10.36922/ijb.4243 ↗
7. 3D-printed mesoporous bioglass/polycaprolactone scaffolds induce macrophage polarization toward M2 phenotype and immunomodulates osteogenic differentiation of BMSCs10.36922/ijb.3551 ↗
8. Bioinspired processing for the sustainable fabrication of high-performance bioinspired ceramic-reinforced polymer composites10.1016/j.matt.2024.09.011 ↗
9. Biodegradable ceramic-polymer composites for biomedical applications: a review10.1016/j.msec.2016.10.014 ↗
10. Biomimetic mineralized 3D-printed polycaprolactone scaffold induced by self-adaptive Nanotopology to accelerate bone regeneration10.1021/acsami.4c02636 ↗
11. Polymer-ceramic composite scaffolds: the effect of hydroxyapatite and β-tri-calcium phosphate
12. Surface modification of nano-hydroxyapatite/polymer composite for bone tissue repair applications: a review10.3390/polym16091263 ↗
13. DLP fabricating of precision GelMA/HAp porous composite scaffold for bone tissue engineering application10.1016/j.compositesb.2022.110163 ↗
14. An overview of collagen/bioceramic and synthetic collagen for bone tissue engineering10.1016/j.mtla.2022.101391 ↗
15. Bone regeneration with hydroxyapatite-based biomaterials10.1007/s42247-019-00063-3 ↗
16. Indirect 3D printing CDHA scaffolds with hierarchical porous structure to promote osteoinductivity and bone regeneration10.1016/j.jmst.2024.04.032 ↗
17. Structures, properties, and bioengineering applications of alginates and hyaluronic acid
18. Dispersion of nanoparticles in polymer matrices with well-designed ligands as dispersant/emulsifier/comonomer10.1016/j.compscitech.2018.01.011 ↗
19. Synergy of hybrid fillers for emerging composite and nanocomposite materials—a review10.3390/polym16131907 ↗
20. High-performance polymer nanocomposites: advanced fabrication methods and critical insights10.1007/s10965-024-04025-0 ↗
21. Tannic acid and quaternized chitosan mediated puerarin-loaded octacalcium phosphate/sodium alginate scaffold for bone tissue engineering10.1016/j.ijbiomac.2024.132632 ↗
22. Supramolecular reinforcement of polymer–nanoparticle hydrogels for modular materials design10.1002/adma.202106941 ↗
23. Supramolecular hybrid structures and gels from host–guest interactions between α-cyclodextrin and PEGylated organosilica nanoparticles10.1021/acs.langmuir.8b01744 ↗
24. Supramolecular hydrogels based on custom-made poly(ether urethane)s and cyclodextrins as potential drug delivery vehicles: design and characterization10.1039/D0TB01261K ↗
25. Inclusion complexes of melatonin with modified cyclodextrins10.1007/s10847-013-0290-5 ↗
26. α-Cyclodextrin concentration-controlled thermo-sensitive supramolecular hydrogels10.1016/j.msec.2017.08.045 ↗
27. Applications and progress of 3D printed bioceramic scaffolds in bone tissue repair and immune regulation10.1016/j.ceramint.2024.09.294 ↗
28. Enhanced osteogenesis and inflammation suppression in 3D printed n-HA/PA66 composite scaffolds with PTH(1-34)-loaded nPDA coatings10.1016/j.compositesb.2024.111566 ↗
29. Engineering surface-adaptive metal–organic framework armor to promote infected wound healing10.1021/acsami.4c20219 ↗
30. Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects10.1007/s00198-023-06836-1 ↗
31. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways: melatonin stimulates osteoblastic differentiation10.1111/j.1600-079X.2011.00875.x ↗
32. Neutrophils and NETs in modulating acute and chronic inflammation10.1182/blood-2018-11-844530 ↗
33. Molecular pathways and biological roles of melatonin and vitamin D; effects on immune system and oxidative stress10.1016/j.intimp.2024.113548 ↗
34. Antioxidant actions of melatonin: a systematic review of animal studies10.3390/antiox13040439 ↗
35. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents10.1038/s41580-020-0230-3 ↗
36. Synthetic polymers for drug, gene, and vaccine delivery10.1021/polymscitech.5c00010 ↗
37. Cyclodextrins: structure, physicochemical properties and pharmaceutical applications10.1016/j.ijpharm.2017.11.018 ↗
38. Investigation of host–guest inclusion complex of mephenesin with α-cyclodextrin for innovative application in biological system
39. Melatonin/cyclodextrin inclusion complexes: a review10.3390/molecules27020445 ↗
40. Structural and physicochemical characterization of the inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin10.1016/S0008-6215(02)00049-6 ↗
41. Alpha-cyclodextrin: enzymatic production and food applications10.1016/j.tifs.2013.11.005 ↗
42. J. Qiu, H. Zhao, S. Luan, L. Wang, H. Shi, Recent advances in functional polyurethane elastomers: from structural design to biomedical applications, Biomater. Sci. (2025) 10.1039.D5BM00122F. doi:https://doi.org/10.1039/D5BM00122F.10.1039/D5BM00122F ↗
43. Hydrophilic polyurethanes: a brief review from the synthesis to biomedical applications
44. Polyethylene glycol-(N-Methylimidazolium) hydroxide-grafted γ-Fe2 O3 @HAp: a novel Nanomagnetic recyclable basic phase-transfer catalyst for the synthesis of tetrahydrobenzopyran derivatives in aqueous media10.1002/jccs.201700401 ↗
45. Biomimetic hydroxyapatite nanorods promote bone regeneration via accelerating osteogenesis of BMSCs through T cell-derived IL-2210.1021/acsnano.1c08281 ↗
46. Nanomaterial-based bone regeneration10.1039/C7NR00835J ↗
47. Cyclodextrin rotaxanes and polyrotaxanes10.1021/cr970027+ ↗
48. Cucurbituril and α- and β-cyclodextrins as ligands for the complexation of nonionic surfactants and polyethyleneglycols in aqueous solutions10.1023/A:1008148831359 ↗
49. Fabrication and characterization of poly(ε-caprolactone)/α-cyclodextrin pseudorotaxane nanofibers10.1021/acs.biomac.5b01379 ↗
50. PEGylated gold nanoparticles: polymer quantification as a function of PEG lengths and nanoparticle dimensions10.1039/C3RA22739A ↗
51. Bone tissue engineering scaffolds: function of multi-material hierarchically structured scaffolds10.1002/adhm.202202766 ↗
52. Assessment of bone ingrowth into porous biomaterials using MICRO-CT10.1016/j.biomaterials.2007.01.046 ↗
53. Synthesis of sodium alginate/polyvinyl alcohol/polyethylene glycol semi-interpenetrating hydrogel as a draw agent for forward osmosis desalination10.1186/s13065-024-01246-8 ↗
54. Sodium alginate/polyvinyl alcohol semi-interpenetrating hydrogels reinforced with PEG-grafted-graphene oxide10.1016/j.ijbiomac.2024.130258 ↗
55. Cyclodextrins: structural, chemical, and physical properties, and applications10.3390/polysaccharides3010001 ↗
56. Solid polymer electrolyte with high ionic conductivity via layer-by-layer deposition10.1021/acs.chemmater.5b04739 ↗
57. Degradation of PEG and non-PEG alginate–chitosan microcapsules in different pH environments10.1016/j.polymdegradstab.2011.09.009 ↗
58. Theoretical analysis of calcium phosphate precipitation in simulated body fluid10.1016/j.biomaterials.2004.05.034 ↗
59. Modification of hydroxyapatite (HA) powder by carboxymethyl chitosan (CMCS) for 3D printing bioceramic bone scaffolds10.1016/j.ceramint.2022.09.021 ↗
60. Microstructures and properties of polycaprolactone/tricalcium phosphate scaffolds containing polyethylene glycol fabricated by 3D printing10.1016/j.ceramint.2022.05.081 ↗
61. High molecular weight biodegradable poly(ethylene glycol) via carboxyl-ester transesterification10.1021/acs.macromol.9b02177 ↗
62. Phase solubility analysis10.1080/10408347008085634 ↗
63. Cyclodextrins as pharmaceutical solubilizers10.1016/j.addr.2007.05.012 ↗
64. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization10.1021/js950534b ↗
65. Formation of inclusion complex of enrofloxacin with 2-hydroxypropyl- β -cyclodextrin10.1080/10717544.2020.1724210 ↗
66. Inclusion complexes of cyclomaltooligosaccharides (cyclodextrins) with melatonin in solid phase10.3998/ark.5550190.0006.e14 ↗
67. Characterization of an inclusion complex of cholesterol and hydroxypropyl-β-cyclodextrin
68. Melatonin/HPβCD complex: microwave synthesis, integration with chitosan scaffolds and inhibitory effects on MG-63CELLS10.1016/j.ijpharm.2015.11.028 ↗
69. L.R. Teixeira, R.D. Sinisterra, R.P. Vieira, A. Scarlatelli-Lima, M.F.D. Moraes, M.C. Doretto, Â.M. Denadai, H. Beraldo, An inclusion compound of the anticonvulsant sodium valproate into α-cyclodextrin: physico-chemical characterization, J. Inclusion Phenom. Macrocyclic Chem. 54 (2006) 133–138. doi:https://doi.org/10.1007/s10847-005-5817-y.10.1007/s10847-005-5817-y ↗
70. Melatonin—a powerful antioxidant in neurodegenerative diseases10.3390/antiox14070819 ↗
71. Zinc and melatonin mediated antimicrobial, anti-inflammatory, and antioxidant coatings accelerate bone defect repair10.1016/j.colsurfb.2024.114335 ↗
72. Melatonin: another avenue for treating osteoporosis?10.1111/jpi.12548 ↗
73. pH-responsive polymers10.1039/C6PY01872F ↗
74. A review of sodium alginate-based hydrogels: structure, mechanisms, applications, and perspectives10.1016/j.ijbiomac.2024.139151 ↗
75. Facile synthesis of pH-responsive sodium alginate/carboxymethyl chitosan hydrogel beads promoted by hydrogen bond10.1016/j.carbpol.2021.118993 ↗
76. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices10.1002/jps.2600521210 ↗
77. Higuchi equation: derivation, applications, use and misuse10.1016/j.ijpharm.2011.03.051 ↗
78. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
79. Preparation of organic-modified magadiite–magnetic nanocomposite particles as an effective nanohybrid drug carrier material for cancer treatment and its properties of sustained release mechanism by korsmeyer–peppas kinetic model10.1007/s10853-021-06181-w ↗
80. Drug-delivery nanoplatform with synergistic regulation of angiogenesis–osteogenesis coupling for promoting vascularized bone regeneration10.1021/acsami.2c23107 ↗
81. Graphene nanomaterials: synthesis, biocompatibility, and cytotoxicity10.3390/ijms19113564 ↗
82. Substituted hydroxyapatite coatings of bone implants10.1039/C9TB02710F ↗
83. Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K/AKT/GSK3β/β-catenin pathway10.7150/thno.36930 ↗
84. How neutrophils shape the immune response: reassessing their multifaceted role in health and disease10.3390/ijms242417583 ↗
85. The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies10.3390/ijms22094642 ↗
86. Understanding reactive oxygen species in bone regeneration: a glance at potential therapeutics and bioengineering applications10.3389/fbioe.2022.836764 ↗
87. A comprehensive review on bio-nanomaterials for medical implants and feasibility studies on fabrication of such implants by additive manufacturing technique10.3390/ma13010092 ↗